Retina

Pilot study shows promise of teaching surgeons with technology.

AbbVie and REGENXBIO announced a strategic partnership to develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases.

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery.

Tunde Peto, MD, offers advice on how to create the best virtual environment for patients diagnosed with diabetic eye disease.

Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.

Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.

Anat Loewenstein, MD, MHA, discusses how artificial intelligence can optimize optical coherence tomography.

A case study details the care of a patient who had already lost vision in one eye from a similar issue.

Carel B. Hoyng, MD, discusses his presenation regarding macula dystrophies, including Stargardt disease, Best disease, X-linked retinoschisis, and the peripherin-2 (PRPH2) gene.

José-Alain Sahel, MD, explains how optogenetics involves artificial photoreceptors from specific retinal cells to restore vision.

Quan Dong Nguyen, MD, MSc, FARVO, FASRS, highlights his presentation regarding new biological treatments of posterior uveitis.

Ramin Tadayoni, MD, PhD, discusses the pathology of myopia around the globe.

Jennifer Sun, MD, MPH, explores the question of whether ophthalmologists should be using anti-VEGF agents to treat patients with nonproliferative diabetic retinopathy (NPDR).

OD-OS’s teleguidance offering addresses the lack of experts and also benefits teaching in retina laser care.

Rhegmatogenous retinal detachment studied.

Development of new animal model enhances study of potential mutations.

Study examines immunomodulatory therapy as a potential long-term treatment option.

Led by eye care nonprofit Orbis with support from Alcon, the training will build eye care professionals' skills to treat retinopathy of prematurity in Latin America

Investigation evaluates safety of single and multiple intravitreal injections.

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.

Systemic immunosuppression may prevent devastating complication in patients.

A new study reveals that children of mothers with diabetes during pregnancy have an increased risk of eye problems.

GT005 designed to induce local production of recombinant complement factor I.

Cotargeted therapy could help combat inherited retinal diseases.

Special to Ophthalmology Times®